Analyst Ratings for Medicenna Therapeutics (MDNA) [Buys]
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
12/18/2020 | Oppenheimer » Updated 8/10/2022 |
Matthew Biegler | New Coverage | Outperform (N/A) |
8.00 (10.00) |
3.82 (0.16) |
-95.81% | Details |